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This study aimed to obtain site-specific and controlled drug release particulate systems. Some particulates were 
prepared using different concentrations of sodium alginate (Na-Alg) alone and others were formulated using 
different proportions of Na-Alg with hydroxypropyl methylcellulose (HPMC) stearoxy ether (60M viscosity 
grade), a hydrophobic form of conventional HPMC, using diclofenac potassium (DP) by ion-exchange methods. 
Beads were characterized by encapsulation efficiency, release profile, swelling, and erosion rate. The suitability 
of common empirical (zero-order, first-order and Higuchi) and semi-empirical (Ritger-Peppas and Peppas-Sahlin) 
models was studied to describe the drug release profile. The Weibull model was also studied. Models were 
tested by non-linear least-square curve fitting. A general purpose mathematical software (MATLAB) was used 
as an analysis tool. In addition, instead of the widely used linear fitting of log-transformed data, direct fitting 
was used to avoid any sort of truncation or transformation errors. The release kinetics of the beads indicated a 
purely relaxation-controlled delivery, referred to as case II transport. Weibull distribution showed a close fit. The 
release of DP from Na-Alg particulates was complete in 5-6 hours, whereas from Na-Alg hydrophobic HPMC 
particulate systems, release was sustained up to 10 hours. Hydrophobic HPMC with Na-Alg is an excellent 
matrix to formulate site-specific and controlled drug release particulate systems. 
Uniterms: Drugs/release particulate systems. Drugs/release profile. Hydroxypropyl methylcellulose stearoxy 
ether. Sodium alginate. Direct fitting. Case II transport. Beads/characterization. Beads/release kinetics. 
Este estudo teve como objetivo a obtenção de sistemas particulados para a liberação controlada de fármacos 
em sítios de ação específicos. Algumas partículas foram preparadas utilizando-se diferentes concentrações de 
alginato de sódio (Na-Alg) e outras foram formuladas por diferentes proporções de Na-Alg com estearoxílico 
éter de hidroxipropilmetilcelulose (HPMC) (grau de viscosidade 60M), uma forma hidrofóbica do convencional 
HPMC, utilizando o diclofenaco de potássio (DP) por métodos de troca iônica. Os grânulos foram caracterizados 
pela eficiência de encapsulação, perfil de liberação, inchaço e taxa de erosão. A adequação de diferentes modelos 
empíricos (de ordem zero, primeira ordem e Higuchi) e semi-empíricos (Ritger-Peppas e Peppas-Sahlin) foi 
estudada para descrever o perfil de liberação do fármaco. O modelo de Weibull também foi estudado. Os modelos 
foram testados através de ajuste não linear de curva pelo método dos mínimos quadrados. O software matemático 
MATLAB foi utilizado como ferramenta de análise matemática. Além disso, em vez do método de ajuste linear 
de dados transformados, foi utilizado o ajuste direto para evitar qualquer tipo de erro de truncamento ou de 
transformação. A cinética de liberação dos grânulos indicou liberação controlada puramente pelo processo de 
relaxamento, referida como transporte caso II. A distribuição de Weibull apresentou bom ajuste. A liberação do 
DP a partir de partículas de Na-Alg foi concluída em 5-6 horas, enquanto que a partir de sistemas particulados 
de Na-Alg HPMC hidrofóbico, a liberação foi mantida por até 10 horas. O HPMC hidrofóbico com Na-Alg é 
uma excelente matriz para a formulação de sistemas particulados para a liberação controlada de fármacos em 
sítios de ação específicos. 
Unitermos: Fármacos/sistemas particulados para a liberação controlada. Fármacos/perfil de liberação. Éter 
esteroxílico de hidroxipropilmetilcelulose. Alginato de sódio. Ajuste direto. Transporte caso II. Grânulos/
caracterização. Grânulos/cinética de liberação.
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INTRODUCTION
The use of biodegradable polysaccharides has 
gained wide acceptance in the development of controlled 
drug delivery systems. Over the past few decades, natural 
biodegradable polysaccharides such as pectin, guar gum, 
chitosan, carrageenans, sodium alginate (Na-alginate), 
hydroxypropyl methylcellulose (HPMC), agar and gellan 
gum have been widely used (Kulkarni et al. 2001; Sri-
amornsak, et al. 2004). These polymers can be exploited in 
various ways in the formulation of targeted and controlled 
drug delivery as they have different derivatizable groups, 
a wide range of molecular weight, and varying chemi-
cal composition. These polymers are also called smart 
materials. They can change their volume in contact with 
external media and form a viscous layer which serves as 
a protective barrier against water influx and drug efflux 
in solution (Sinha, Rohera 2002). Thus, immediate drug 
release is prevented, and a sustained drug release rate can 
be achieved. A number of studies have investigated the 
use of hydrogel beads as a multiparticulate system for 
site-specific and controlled drug delivery. Hydrogel beads 
have many advantages over single-unit systems, such as 
uniform dispersion in the gastrointestinal (GI) tract, more 
uniform drug absorption, less inter- and intra-individual 
variability, and most importantly, targeted and controlled 
drug delivery. The methods for bead preparation are easily 
performed and reproducible. The polymers and carriers 
used in the preparation are nontoxic, readily available, 
and relatively non-expensive. Among various polymers, 
Na-alginate (Acikgoz et al. 1995; Gursoy, Cevic 2000; Be-
lyaeva et al. 2005) stands as the polymer of choice for bead 
preparation. It is a natural bioerodible polyacid and the 
only polymer (Gacesa 1988; Smidsrd, Skjak-Bræk 1990; 
Shu, Zhu 2002) that has a unique property of gel formation 
in the presence of multivalent cations, such as calcium 
ions and aluminum ions in aqueous media, which takes 
place mainly at junctions in the G-G sequence rich chain 
region known as the ‘egg box junctions’. Bead formation is 
obtained by incorporation of the drug into a gel dispersion 
system, and the hydrophilic colloids (Gonzalez-Rodrıguez 
et al. 2002) then interact with polyvalent metal ions to 
form insoluble colloidal complexes (calcium alginate), 
droplets that will precipitate in bead form. This system is 
generally formed by ionotropic cross-linking of natural 
biodegradable polysaccharides, but the resulting calcium 
alginate bead is usually very permeable, making it very 
difficult to control drug release for a prolonged period 
of time (Lin, Ayres 1992; Østberg et al. 1994; Ferreira, 
Almeida 2004). This problem can be minimized by mix-
ing alginate with other polymers such as pectin, chitosan, 
ethylcellulose, and Eudragit®. This is a useful combina-
tion due to modifications made to the original formulation 
of highly permeable calcium alginate beads. Conventional 
hydrophilic HPMC is a very useful polymer in the prepara-
tion of controlled drug delivery formulations (Das, Ahmed 
2007; Ganesh et al. 2008). A hydrophobic form of HPMC 
is currently available and has been modified from con-
ventional HPMC by inserting a long-chain alkyl group. 
Various hydrophobic groups are generally inserted into the 
conventional polymer backbone to modify drug release for 
improved therapeutic activity, and this hydrophobicity will 
certainly modify drug release. In our recent paper, we have 
shown the ability of a modified hydrophobic HPMC poly-
mer (Ghosal et al. 2010) to form a high-viscosity hydrogel 
using a very small amount of material. In our present study, 
we extend the investigation by using this newly modified 
polymer in combination with Na-alginate to form beads 
and to check the sustainability of the therapeutic effect 
obtained from this new matrix. Generally, alginate beads 
start to dissolve above (Sabnis et al. 1997) pH 7; thus, drug 
release will bypass the gastric environment, and direct 
contact of the drug with the gastric mucosa is prevented. 
Diclofenac potassium (DP) was chosen as a model drug. 
DP, a nonsteroidal anti-inflammatory drug (NSAID), is 
widely used because of its strong analgesic, antipyretic 
and anti-inflammatory effects (Escribanoa et al. 2003; 
Sintov, Botner 2006; Sanna et al. 2009). DP is available 
on the market as injections, oral sustained-release tablets, 
and topical formulations. Although DP has been shown 
to be one of the best tolerated NSAIDs, gastropathy oc-
curs following oral administration, and because of its 
short biological half-life (1-2 hours), the drug has to be 
administered frequently. DP is poorly soluble (Lin, Kao 
1991; Fernandez-Hervas et al. 1998) in water and acidic 
pH, but rapidly soluble in alkaline pH. Thus, an attempt 
was made to formulate hydrogel beads containing alginate 
and hydrophobic HPMC (60M) in different ratios for 
controlled release in alkaline pH, which would eliminate 
the need for multiple dosing, thereby increasing patient 
compliance and decreasing the occurrence of adverse ef-
fects in the stomach. Release characteristics in different 
pH ranges, entrapment efficiency, polymer morphology, 
swelling capacity and erosion were investigated.
In this study, we compared these modified beads 
with bead formulations of alginate alone. Additionally, 
we aimed to perform some of the theoretical approaches 
describing drug release through the matrix. The drug is 
often released via molecular diffusion through the porous 
structure within the polymer network. For alginate beads, 
the matrix undergoes a combination of swelling with 
erosion and rapid destruction. However, if hydrophobic 
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HPMC is added, drug release may be mainly dominated 
by swelling, with very slow erosion and destruction of the 
polymer. Thus, a retarded drug release can be expected. 
For this purpose, we examined whether these two types 
of beads would show a Fickian type or anomalous diffu-
sion type of release profile by applying the Ritger-Peppas 
equation, which helps to get a release exponent that char-
acterizes the mechanism of drug release. An extension of 
the power-law model was also applied to obtain the frac-
tion of drug released by diffusion alone (Peppas, Sahlin 
1989). This equation provides information on the relative 
contributions of drug diffusion and polymer relaxation to 
overall drug release. The equations most commonly used 
for in vitro data analysis are the Higuchi equation and 
zero-order kinetics. Residuals were plotted against time 
to obtain further insight into the data to assess the good-
ness of fit of the models. The Weibull distribution model 
was also included. This model alone cannot describe 
the kinetic properties of the drug, but it can describe the 
curve in terms of shape parameter (Leticia et al. 2004). 
Linear transformation methods were deliberately avoided, 
because in these methods, values are calculated mainly 
from log-transformed data, instead of original data, and 
approximation errors may accumulate over time, thereby 
interfering with the analysis.
MATERIAL AND METHODS
The following materials were obtained from the 
indicated suppliers and used as received: DP (IP grade) 
was kindly donated by M/S Kontest Chemicals, Kolkata, 
India. Hydrophobic HPMC or HPMC stearoxy ether (60 M 
viscosity grade) was kindly donated by Daido Chemical 
Corporation, Tokyo, Japan. Na-alginate (low viscosity; 
viscosity of 2% solution at 25 °C, 250 cps), calcium 
chloride hexahydrate, anhydrous disodium hydrogen 
phosphate, and potassium dihydrogen phosphate were 
purchased from Merck, India. Other chemical reagents 
were obtained at the highest purity level available from 
the manufacturers. 
Methods
Analytical method
About 100 mg of DP was accurately weighed, trans-
ferred into a l00-mL volumetric flask and dissolved in 
methanol; 10 mL of this solution was then transferred into 
a 100-mL volumetric flask. Different primary standards 
were prepared to generate a calibration curve, which was 
obtained by measuring their absorbance at 275 nm with 
an ultraviolet-visible (UV-vis) spectrophotometer. DP 
concentration was calculated using the linear regression 
equation of the calibration curve. When a standard drug 
solution (2 μg/mL) was assayed repeatedly (n = 6), mean 
standard error (accuracy) and residual standard deviation 
(precision) were found to be 0.4% and 0.6%, respectively.
Preparation of beads
DP (2.0% w/v) was added to aqueous solutions 
of varying proportions of Na-alginate and hydrophobic 
HPMC and stirred until complete dissolution. This so-
lution was dropped using a hypodermic syringe (20 G) 
into a second solution, containing a saturated solution of 
calcium chloride (3% w/v). Microspheres were formed 
immediately and left in the original solution for 30 min to 
ensure internal gelification. The microspheres were then 
filtered, washed and dried at room temperature. The whole 
preparation process was carried out at room temperature. 
Table I shows bead composition.
Characterization of diclofenac potassium-loaded 
alginate and modified hydrophobic HPMC alginate-
based hydrogel beads
· Particle size determination
After drying at 37 °C for 48 hours, a sieving method 
using USP standard sieves (Jain et al. 2007) was used to 
measure the mean diameter of the dried beads. Shape pa-
rameters (such as area, perimeter, shape factor, and equiva-
lent circular diameter) were calculated to characterize DP 
beads (Gonzalez-Rodrıguez et al., 2002). The equivalent 
circular diameter (ECD) was calculated as follows: 
ECD=2√A/π
where A is the area of the closed boundary of the 
particle. Shape factor is used to measure object complex-
ity, namely contour complexity. The greater the variation 
of the contour, the higher the shape factor parameter. The 
value of shape factor (s) is determined as follows:
s=L2/4 πA
where L is the perimeter and A is the area of the closed 
boundary of the particle.
· Entrapment efficiency 
Specific amounts of beads were placed in a glass 
mortar. The beads were crushed into fine powder and 
dissolved in 1 M sodium hydroxide solution for 24 hours 
in a graduated flask. The solution was filtered through a 
G2 filter. The clear liquid was assayed for drug content 
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of beads by UV-vis spectrophotometry at 275 nm. This is 
the actual amount of drug entrapped in the beads. Entrap-
ment efficiency (EE) was calculated using the following 
formula: 
EE = b X 100/a 
b = actual amount of drug present in bead.
a = theoretical amount of drug in bead.
· Swelling capacity
Beads were placed in a watch glass, and distilled 
water was added. Initial bead weight (W0) and bead weight 
at different time points (Wt) were measured. The swelling 
capacity of the individual beads was estimated as the ratio 
of weight at different time points to initial bead weight 
(Wt/W0). The beads were handled carefully to avoid losses. 
Diameters were measured by the sieving method using 
USP standard sieves (Ebube et al., 1997). Each experiment 
was done in triplicate.
· Erosion studies
The dried beads were weighed and placed in a dis-
solution basket (Srinatha et al., 2008; Rao et al., 1988; 
Yotsuyanagi et al., 1991), followed by dissolution in phos-
phate buffer (pH 7.4) at 50 rpm. After a 1-hour interval, 
the beads were removed from the basket and oven-dried 
at 50 °C. The water was removed, and the beads were 
weighed. The beads were then placed back in the basket. 
This process lasted 10 hours. Erosion study was performed 
using the following formula: 
wo = Initial bead weight, w1 = weight after drying.
·Release tests (Lin, Ayres 1992): 
Drug release profiles of DP-containing formula-
tions with an accurately weighed amount of beads were 
obtained using USP dissolution apparatus II (Shimadzu 
1202 UV VIS-spectrophotometer). The study conditions 
were: a stirring speed of 50 rpm and 900 mL of dissolution 
medium at 37±0.2 ºC. The simulation of GI transit condi-
tions was achieved by changing the pH of the dissolution 
medium at different time intervals. For the first 2 hours, pH 
of the dissolution medium was buffered at pH 1.2 (HCl/
NaCl, to mimic the gastric district). The pH was then raised 
to 6.4 (phosphate buffer) and maintained at this value for 
another 2 hours. Finally, a slightly higher pH (7.4) was 
used up to 6 hours. At predetermined intervals, a 3-mL 
aliquot was withdrawn and replaced with fresh dissolu-
tion medium. The withdrawn samples were filtered and 
analyzed spectrophotometrically at 275 nm. All samples 
were measured in triplicate, and the results were expressed 
as the percentage of drug released.
· Release kinetics study
DP release from beads was studied by various math-
ematical models. These models were applied taking into 
account the amount of drug released from 1 to 10 hours at 
different intervals as determined in release studies in vitro. 
Zero-order linear equation, Higuchi square root of 
time equation and Weibull model were used to describe the 
kinetics of drug release from different formulations, and 
Ritger-Peppas’ power-law equation and Peppas-Sahlin’s 
weighted sum of non-linear time function (semi-empirical 
kinetic equations) were used only for the first 60% of 
drug released to denote the type of diffusion and fraction 
of drug release due to Fickian diffusion, respectively. 
All model-fitting analyses were performed by non-linear 
direct fitting through minimization of the sum of squared 
residuals (SSR). A general purpose mathematical software 
(MATLABTM) was used as an analysis tool. 
Three equations employed in this study, zero-order 
model, Higuchi square root equation and Ritger-Peppas 
model, are widely used due to their simplicity and appli-
cability (Li et al., 2006).
The mathematical expressions for the semi-empiri-
cal models are as follows:
   (1)
  (2)
   (3)
   (4)
where Qt is the cumulative percentage amount of drug 
released at time t, Q0 is the initial amount of drug in gel, 
K0, KH, KRP, K1, K2 are release rate constants, and C0, CH 
are the respective y-intercepts in the absorbance vs. time 
curve. Ritger-Peppas and Peppas-Sahlin models were used 
specifically to explore release mechanisms and the fraction 
of drug release (due to diffusion), respectively. During 
the Ritger-Peppas model fitting, we obtained the value 
of the release exponent n, which conveys information on 
whether the release mechanism is Fickian, non-Fickian 
or case II transport mechanism. In this context, n = 0.5 
indicates Fickian release (diffusionally controlled release) 
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and n = 1 indicates a purely relaxation-controlled delivery, 
which is referred to as case II transport. When the value 
of n is intermediate, it indicates an anomalous behavior 
(non-Fickian kinetics corresponding to coupled diffusion/
polymer relaxation). A value of n > 1 indicates super case 
II kinetics. Based on the Peppas-Sahlin model, the fraction 
of drug release
   (4)
due to diffusion at a given instant of time t can be calcu-
lated from (4) if K1 and K2 values are available.
Regarding statistical models, the underlying idea 
behind the use of statistical distribution in the modeling of 
drug release is to match the cumulative distribution func-
tion (CDF) of a particular distribution with the cumulative 
drug release; the underlying random variable (RV) being 
time t. CDF expressions in terms of RV are summarized 
as follows:
Weibull distribution:  (5)
Although linear fitting of log-transformed data is 
widely used, direct fitting was used here to avoid trunca-
tion or transformation errors. The goodness of fit was 
based on value of the regression coefficient (r2) and SSR. 
· Stability test
For stability testing, the beads were kept at differ-
ent temperature conditions, such as room temperature, 
8±1°C (refrigerator temperature), and 30±2°C (condition 
for accelerated stability testing). Accelerated stability 
testing was performed at 75±5% relative humidity (RH). 
The samples were withdrawn at different time intervals 
(0, 1, and 3 months). Physical stability of the samples 
was determined by visual inspection. Chemical stability 
studies were carried out by measuring drug content and 
release profile.
· Data and statistical analysis
The steady-state release rate was calculated from the 
slope of the linear plot of the % cumulative drug released 
as a function of time (t, hours).
Data are presented as mean ± standard deviation 
(SD). Statistical comparisons were made using the Student 
t test. The level of significance was set p < 0.05. Data were 
analyzed using MS-excel software.
RESULTS AND DISCUSSION
Particle size
The spherical shape of alginate beads was obtained 
by using a Na-alginate concentration above 1.5%. Beads 
are generally found to remain spherical even after dry-
ing. In this study, all beads prepared with Na-alginate 
alone exhibited a spherical shape, and after addition of 
hydrophobic HPMC, no change was observed in their 
macroscopic features (Figures 1 and 2). Figures 1 and 2 
clearly show that beads prepared with Na-alginate alone 
and Na-alginate/hydrophobic HPMC were spherical in 
shape.
FIGURE 1 - Spherical shape of beads prepared with sodium 
alginate (SA) alone.
FIGURE 2- Spherical shape of beads prepared with sodium 
alginate (SA) and hydrophobic hydroxypropyl methylcellulose 
(HPMC).
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As described in Table II, the resulting beads were 
smaller, with ECD ranging from 3.24 to 4.04 mm. There 
was no significant variation in particle size among the dif-
ferent formulations. The beads shrank upon drying, which 
generally occurs due to cross-linking of the polymer, and 
the drug entrapped within this cross-link is released in a 
retarded manner. Shape factors are generally used when 
studying a multiparticulate system. The beads, which are 
highly irregular in shape, exhibited large shape factor 
values, often ranging from 0.708 to 0.853. These shape 
factor values show that the beads achieved a spherical 
shape. Area and perimeter were within 9.07-12.81 mm2 
and 9.00-10.90 mm, respectively. An average of six read-
ings was recorded (mean ± SD).
Entrapment efficiency
Entrapment efficiency is an important parameter for 
beads and generally depends on curing time in the coagula-
tion fluid (calcium chloride solution). The drug can diffuse 
into the fluid, and higher curing time means higher drug 
diffusion into the fluid. As a result, the amount of drug 
entrapped in the beads decreases. In this study, curing time 
(30 min) was the same for all beads, and the average amount 
of drug entrapped in the beads was about 78-87% (Table 
III). An average of six readings was recorded (mean ± SD).
Swelling capacity
The swelling profile of hydrophobic HPMC/Na-al-
ginate beads and beads with Na-alginate alone in distilled 
water is shown in Table IV. When phosphate buffer is used, 
the swelling rate of beads cannot be estimated because of 
very quick erosion. When immersed in distilled water, 
Na-alginate beads immediately begin to swell, recover-
ing their initial spherical shape. On the other hand, cross-
linked hydrophobic HPMC/Na-alginate beads initially 
exhibit a more rapid diameter increase, which slows down 
after 15 min, while keeping their shape. Water uptake 
increases with time, leading to an initial loss of spherical 
shape within 3 hours. The swelling rate of beads tended 
to decrease as the concentration of hydrophobic HPMC 
TABLE I - Composition of different formulations used for 
preparation of diclofenac potassium microspheres
Fn Sodium 
alginate 
(% w/v)
Hydrophobic 
HPMC 
(% w/v)
Diclofenac 
potassium 
(% w/v)
S1 2.00 - 2.00
S2 2.50 - 2.00
S3 3.00 - 2.00
A1 2.00 0.20 2.00
A2 2.00 0.50 2.00
A3 2.00 0.80 2.00
B1 2.50 0.20 2.00
B2 2.50 0.50 2.00
B3 2.50 0.80 2.00
C1 3.00 0.20 2.00
C2 3.00 0.50 2.00
C3 3.00 0.80 2.00
Fn = formulation, HPMC = hydroxypropyl methylcellulose. 
TABLE II - Shape parameters of the different formulations
Formulation Area (mm2) Perimeter (mm) Shape Shape factor ECD (mm)
S1 9.07 ± 0.01 9.82 ± 0.09 spherical 0.846 ± 0.12 3.40 ± 0.11
S2 9.33 ± 0.02 10.00 ± 0.16 spherical 0.853 ± 0.11 3.45 ± 0.16
S3 8.23 ± 0.03 9.00 ± 0.21 spherical 0.783 ± 0.14 3.24 ± 0.12
A1 12.62 ± 0.01 11.02 ± 0.11 spherical 0.708 ± 0.12 4.01 ± 0.22
A2 10.39 ± 0.02 10.10 ± 0.19 spherical 0.782 ± 0.21 3.64 ± 0.18
A3 12.52 ± 0.01 11.00 ± 0.21 spherical 0.769 ± 0.19 4.00 ± 0.08
B1 9.33 ± 0.02 10.01 ± 0.15 spherical 0.855 ± 0.16 3.45 ± 0.10
B2 12.69 ± 0.11 11.00 ± 0.12 spherical 0.759 ± 0.17 4.02 ± 0.12
B3 12.81 ± 0.09 11.05 ± 0.22 spherical 0.759 ± 0.18 4.04 ± 0.11
C1 12.50 ± 0.10 10.90 ± 0.119 spherical 0.757 ± 0.19 3.99 ± 0.20
C2 9.07 ± 0.07 9.65 ± 0.21 spherical 0.817 ± 0.16 3.40 ± 0.12
C3 9.89 ± 0.03 9.69 ± 0.09 spherical 0.756 ± 0.15 3.55 ± 0.17
ECD = equivalent circular diameter.
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TABLE III -Entrapment efficiency of microspheres
Fn Entrapment efficiency (% w/w) 
(Mean ± SD)
S1 87.44±2.50
S2 81.74±1.11
S3 83.88±1.23
A1 85.55±2.01
A2 82.54±1.21
A3 87.55±1.41
B1 83.76±2.01
B2 77.89±2.03
B3 79.65±1.43
C1 82.48±1.23
C2 80.90±1.65
C3 81.32±1.77
Fn = formulation; SD = standard deviation.
TABLE IV - Swelling characteristics of sodium alginate (Na-
alginate) beads and hydrophobic hydroxypropyl methylcellulose 
(HPMC)/Na-alginate beads
Fn Swelling rate 
(Mean ± SD)
Regression 
coefficient (r2)
S1 19.32 ± 0.01 0.9804
A1 18.56 ± 0.01 0.9901
A2 15.01± 0.03 0.9802
A3 10.09 ± 0.02 0.99921
Fn = formulation, SD = standard deviation.
increased due to strong interaction between two oppositely 
charged polymers. Incorporation of hydrophobic HPMC 
prolonged the swelling properties of beads, because hy-
drophobic HPMC provided higher viscosity levels than 
Na-alginate, thus preventing a quick loss of the initial 
spherical shape. The swelling rate of beads was obtained 
from the slope of the relationship between % swelling 
capacity and time. This relationship provided good linear-
ity (r2 > 0.98) when assessed by linear regression analysis 
(Table IV). In this study, we compared swelling capacity 
between Na-alginate beads (S1) and Na-alginate/hydro-
phobic HPMC beads (from A1 to A3). Average swelling 
capacity of six beads was shown (mean ± SD). The swell-
ing rate of Na-alginate beads is 19.32, and as the polymer 
content in formulation increases (S3>S2>S1), the swell-
ing rate decreases (10.09<15.01<18.56). The presence of 
hydrophobic HPMC in the beads maintained swelling for 
a longer time than Na-alginate alone. 
Erosion studies
Results are plotted in Figure 3. In erosion tests 
run in phosphate buffer (pH 7.4), both types of beads 
exhibited an initial increase in volume. Na-alginate beads 
started to erode significantly at 30-45 min, losing their 
spherical shape after 120-180 min, whereas the cross-
linked formulations kept their shape throughout the test 
(50% integrity after 4 hours). This feature was also ob-
served throughout the drug release tests and is probably 
the main cause underlying the prolonged release of the 
drug from the beads.
Release tests
Drug release profiles of beads are shown in Figures 
4, 5, 6, and 7. Alginate is insoluble in acidic pH. At low 
pH, the number of positively charged ions is high, and 
they reduce the electrical repulsion between the nega-
tively charged alginate molecules (Gonzalez-Rodrıguez 
et al., 2002). Alginate is protonated into the insoluble 
form of alginic acid. Thus, penetration of dissolution 
fluid through the polymer is hindered, and the percentage 
of drug released due to diffusion through the polymer 
network was minimal at pH 1.2 for all beads. Initial drug 
release (up to 12%) may be attributed to the leaching of 
the drug on the bead outer surface. When pH is increased, 
drug release increases up to 100%. Deprotonation of al-
ginic acid occurs at higher pH values. It will draw fluid 
into the beads, which swell and burst apart. Thus, drug 
release rate increases at basic pH. Three types of hydro-
gel beads were formulated using 2.0, 2.5 and 3.0% w/v 
concentrations of Na-alginate alone. All beads released 
the drug within 6 hours. As the polymer concentration 
increased, diffusional resistance to drug release also in-
FIGURE 3 - % weight loss of different hydrogel beads due to 
erosion.
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creased, which, in turn, decreased drug release. It is clear 
that as the polymer content in the formulation increases 
(S3>S2>S1), % cumulative drug release at a 6-hour in-
terval (98.57<98.67<99.69) decreases. 
Combination of alginate and hydrophobic HPMC 
produced a sustained effect on drug release in the formu-
lations. Conventional HPMC was combined with a small 
amount of a long-chain alkyl group to obtain HPMC 
stearoxy ether. This modified hydrophobic HPMC has 
a higher positive charge due to the presence of a long-
chain alkyl group. Na-alginate is a polyanionic polymer. 
Carboxylate groups are present on the Na-alginate chain. 
Positively charged groups of hydrophobic HPMC strongly 
interact with alginate and diclofenac ions, thus reducing 
both swelling and release – probably due to protonation 
of carboxylated groups from Na-alginate.
In this study, different combinations of alginate and 
hydrophobic HPMC beads were prepared. Na-alginate 
concentration was fixed at 2.0, 2.5 and 3.0% w/v, and 0.2, 
0.5 and 0.8% hydrophobic HPMC were added to prepare 
A1 to C3 formulations (total of 9 formulations). Addition 
of hydrophobic HPMC was shown to sustain drug release 
for a longer period of time (for A1, A2 and A3, 7 hours; 
for B1, B2, B3, 8 hours; and for C1, C2 and C3, 10 hours). 
The alginate/hydrophobic HPMC combination provided 
an alternative system for controlling the release of DP in 
bead form. This study also showed, as observed in Figures 
5, 6, and 7, that as the polymer content in the combined 
formulation increases, % cumulative drug release at a 
6-hour interval decreases. Although the amount of hydro-
phobic HPMC used (0.2, 0.5, and 0.8% w/v) is very low, 
it can retard drug release for a long period of time. High 
viscosity was obtained due to the hydrophobic interaction 
of the long-chain alkyl group, and based on Fick’s law of 
diffusion, it may be inferred that as the viscosity of the 
formulation increases, molecular diffusivity (diffusion 
coefficient) and % release also decrease. 
FIGURE 4 - Comparative results of in vitro release profile of 
hydroxypropyl methylcellulose (HPMC) with sodium alginate 
(SA)-based diclofenac beads.
FIGURE 5 - Comparative results of in vitro release profile of 
hydroxypropyl methylcellulose (HPMC) with sodium alginate 
(SA)-based diclofenac beads.
FIGURE 6 - Comparative results of in vitro release profile of 
hydroxypropyl methylcellulose (HPMC) with sodium alginate 
(SA)-based diclofenac beads.
FIGURE 7 - Plot of % cumulative drug release vs. time (in 
hours). Data expressed as mean ± standard deviation (n=6).
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Release kinetics study
As observed in Table V, the correlation coefficient 
(r2) and SSR for zero-order ranged from 0.9527 to 0.9876 
and from 141.28 to 384.53, respectively, demonstrating 
that drug release follows zero-order kinetics. The correla-
tion coefficient and SSR for Higuchi equation ranged from 
0.9262 to 0.9671 and from 287.93 to 544.82, respectively; 
however, it was not possible to conclude that drug release 
is totally based on diffusion. In order to obtain a clearer 
view of the release process, the Ritger-Peppas model was 
used. Table VI shows that the highest r2 values (ranging 
from 0.9393 to 0.9834) and lowest SSR values (ranging 
from 176.08 to 518.69) were obtained from this model, 
meaning that the best release pattern can be analyzed by 
this model. This model yielded n values that were higher 
than 1, which may be regarded as super case II kinetics 
arising from a reduction in the attractive forces between 
polymer chains. In this study, drug release was dependent 
on the relaxation rate of polymer chains. At higher pH, 
deprotonation of alginic acid weakens the extent of inter-
action, and polymers within the microsphere are found in 
the relaxed form. Addition of hydrophobic HPMC leads 
to a greater retarded release due to increased concentra-
TABLE V - Parameter and correlation coefficients for zero-order equation, Higuchi equation, and Weibull distribution
Fn
Zero-order: Q = KO + C Higuchi: Q = KH t 0.5 + C
Weibull distribution: 
log [ln (1/1-m)] = β log (t) – log(a).
K0 C r2 SSR KH C r2 SSR a β r2 SSR
S1 20.74 -16.83 0.9574 334.94 71.68 -73.63 0.9332 438.62 42.18 2.92 0.9879 0.0096
S2 21.05 -20.46 0.9527 384.53 72.55 -77.76 0.9348 530.40 55.31 3.05 0.9841 0.0129
S3 21.60 -24.05 0.9558 377.98 74.40 -82.76 0.9262 544.82 73.70 3.22 0.9865 0.0115
A1 16.78 -12.67 0.9713 232.77 61.88 -64.67 0.9568 269.52 28.37 2.34 0.9882 0.0096
A2 16.79 -16.54 0.9746 206.12 61.50 -67.78 0.9573 346.07 36.56 2.39 0.9804 0.0158
A3 16.85 -17.41 0.9756 199.23 61.79 -68.98 0.9509 318.94 35.70 2.36 0.9766 0.0191
B1 14.43 -11.18 0.9820 160.77 56.01 -60.39 0.9633 287.93 31.66 2.20 0.9906 0.0084
B2 14.72 -15.70 0.9828 159.74 56.77 -65.16 0.9517 354.92 49.66 2.40 0.9889 0.0103
B3 14.72 -18.64 0.9826 161.35 56.42 -67.40 0.9500 463.11 67.94 2.51 0.9842 0.0147
C1 11.43 -9.11 0.9712 320.29 48.75 -55.77 0.9671 364.83 49.88 2.22 0.9979 0.0024
C2 11.70 -15.02 0.9876 141.49 49.15 -61.13 0.9552 511.82 94.26 2.45 0.9940 0.0069
C3 11.27 -15.74 0.9867 141.28 47.27 -59.96 0.9505 526.01 94.25 2.38 0.9895 0.0111
Fn = formulation, Q = % cumulative amount of release, t = time in hours, K0 = zero-order constant, C = intercept, KH = Higuchi 
constant, m = accumulated fraction of the drug; β = shape parameter; a = scale parameter, r2 = regression coefficient, SSR = sum 
of squared residuals.
tion and viscosity. According to the Peppas-Sahlin model, 
a negative value of K1 was obtained (Table V), which can 
be reported as an insignificant effect of Fickian diffusion 
on drug release compared to the relaxation process.
The Weibull distribution cannot describe drug re-
lease kinetics, but it can describe the curve in terms of 
applicable parameters. As the value for shape parameter 
(β) was higher than 1, plots should be “S” shaped with 
an upward curvature. The values for β, r2, SSR and a are 
described in Table V. The Weibull distribution gave a good 
fit for the data when explaining in vitro release profile, as r2 
(0.9766- 0.9906) had the highest and SSR (0.0024-0.0191) 
the lowest values. 
STABILITY STUDY
Stability testing was performed at different tempera-
tures and conditions. However, no significant reduction 
was observed in the percentage of drug retained in the 
formulations. Likewise, there was no significant difference 
in drug release profile between samples stored at 2-8°C 
and at room temperature. Because DP is a light-sensitive 
drug, it was suggested that formulations should be pro-
tected from light.
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CONCLUSION
A new matrix using Na-alginate and hydrophobic 
HPMC was prepared and used in the controlled release of 
diclofenac. We demonstrated that it is possible to prepare 
diclofenac-loaded beads with high encapsulation effi-
ciency and high swelling capacity. The method developed 
is simple, fast and reproducible. A remarkable delay in 
the release of diclofenac was observed for Na-alginate 
HPMC beads. This matrix also offered a degree of protec-
tion against premature drug release in simulated upper GI 
transit conditions. Matrix swelling induced by phosphate 
buffer did not lead to complete destruction of Na-alginate 
HPMC beads, which results in prolonged retention of the 
drug within the polymer matrix.
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